Description
For Research Lab Use Only, Dry Lyophilized powder, reconstitution required. Bac water not included.
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic, long-acting analog of growth hormone-releasing hormone (GHRH) (1-29) designed to stimulate sustained, elevated pituitary growth hormone (GH) and IGF-1 secretion. By incorporating DAC technology, it binds covalently to serum albumin, extending its half-life to approximately 8 days.
Scientific Description and Mechanism of Action:
- Structure: Modified GHRH (1-29), consisting of 30 amino acids.
- DAC Technology: The addition of Drug Affinity Complex allows the peptide to bind to albumin in the bloodstream, significantly increasing its stability and half-life from minutes to days, requiring fewer injections.
- Function: It acts as a GHRH receptor agonist, stimulating the pituitary gland to produce more natural growth hormone, promoting a steady-state elevation of IGF-1.
- Pharmacokinetics: Unlike CJC-1295 without DAC (Mod GRF 1-29), the DAC version provides a continuous, long-lasting release of growth hormone rather than mimicking the natural, pulsatile rhythm.
